Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Not yet recruiting · NCT07436611 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains | Neoplasms by Histologic Type, capillary hemangioma, hemangioma, neoplasm, vascular cancer | Not yet recruiting | Phase 2 | 2026-07-01 | NCT07436611 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AFT Pharmaceuticals, Ltd. | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Driscoll Children's Hospital | Corpus Christi | United States | 61 |
| Sant Joan de Déu University Hospital | Barcelona | Spain | 1 |